EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Examining the impact of COVID-19 disruptions on population-based breast cancer screening in Ireland

Jessica O'Driscoll iD, Therese Mooney, Paul Kearney, Yvonne Williams, Suzanne Lynch, Alissa Connors, Aideen Larke, Sorcha McNally, Ann O'Doherty, Laura Murphy, Kathleen E Bennett, Patricia Fitzpatrick und 2 weitere

Journal of Medical Screening · 2024

DOI: 10.1177/09691413241232899 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Screening, 2024. Verfasst von Jessica O'Driscoll und 13 weiteren Autor:innen. Beteiligte Einrichtung: School of Population Health, RCSI University of Medicine and Health Sciences, Dublin, Ireland. Hauptthemen laut MEDLINE: COVID-19, Breast Neoplasms, Mammography, Early Detection of Cancer. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: The Health Research Board of Ireland.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Many population-based breast screening programmes temporarily suspended routine screening following the COVID-19 pandemic onset. This study aimed to describe screening mammography utilisation and the pattern of screen-detected breast cancer diagnoses following COVID-19-related screening disruptions in Ireland.

Methods

Using anonymous aggregate data from women invited for routine screening, three time periods were examined: (1) January–December 2019, (2) January–December 2020, and (3) January–December 2021. Descriptive statistics were conducted and comparisons between groups were performed using chi-square tests.

Results

In 2020, screening mammography capacity fell by 67.1% compared to 2019; recovering to 75% of mammograms performed in 2019, during 2021. Compared to 2019, for screen-detected invasive breast cancers, a reduction in Grade 1 (14.2% vs. 17.2%) and Grade 2 tumours (53.4% vs. 58.0%) and an increase in Grade 3 tumours (32.4% vs. 24.8%) was observed in 2020 ( p = 0.03); whereas an increase in Grade 2 tumours (63.3% vs. 58.0%) and a reduction in Grade 3 tumours (19.6% vs. 24.8%) was found in 2021 ( p = 0.02). No changes in oestrogen receptor-positive or nodal-positive diagnoses were observed; however the proportion of oestrogen/progesterone receptor-positive breast cancers significantly increased in 2020 (76.2%; p < 0.01) and 2021 (78.7%; p < 0.001) compared to 2019 (67.8%).

Conclusion

These findings demonstrate signs of a grade change for screen-detected invasive breast cancers early in the pandemic, with recovery evident in 2021, and without an increase in nodal positivity. Future studies are needed to determine the COVID-19 impact on long-term breast cancer outcomes including mortality.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Breast NeoplasmsMammographyEarly Detection of CancerHumansFemaleIrelandMiddle AgedAgedSARS-CoV-2Mass ScreeningAdult

Stichwörter der Autor:innen

COVID-19breast screeningmammography

Autor:innen und Institutionen

  • School of Population Health, RCSI University of Medicine and Health Sciences, Dublin, Ireland.
  • National Screening Service, Dublin, Ireland.
  • Health Service Executive, Dublin, Ireland.
  • BreastCheck, National Screening Service, Ireland.
  • School of Public Health, Physiotherapy & Sports Science, University College Dublin, Ireland.

ORCID-Profile: Jessica O'Driscoll

Förderung

  • The Health Research Board of Ireland

Zitieren

APA

O'Driscoll, J., Mooney, T., Kearney, P., Williams, Y., Lynch, S., Connors, A., Larke, A., McNally, S., O'Doherty, A., Murphy, L., Bennett, K. E., Fitzpatrick, P., Mullooly, M., & Flanagan, F. (2024). Examining the impact of COVID-19 disruptions on population-based breast cancer screening in Ireland. Journal of Medical Screening. https://doi.org/10.1177/09691413241232899

Vancouver

O'Driscoll J, Mooney T, Kearney P, Williams Y, Lynch S, Connors A, et al. Examining the impact of COVID-19 disruptions on population-based breast cancer screening in Ireland. Journal of Medical Screening. 2024. doi:10.1177/09691413241232899

BibTeX
@article{ODriscoll2024,
  author = {O'Driscoll, Jessica and Mooney, Therese and Kearney, Paul and Williams, Yvonne and Lynch, Suzanne and Connors, Alissa and Larke, Aideen and McNally, Sorcha and O'Doherty, Ann and Murphy, Laura and Bennett, Kathleen E and Fitzpatrick, Patricia and Mullooly, Maeve and Flanagan, Fidelma},
  title = {Examining the impact of COVID-19 disruptions on population-based breast cancer screening in Ireland},
  journal = {Journal of Medical Screening},
  year = {2024},
  doi = {10.1177/09691413241232899}
}
Kostenlos starten →